trial
as of 2026-07-01Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
NCTId NCT02051387
at a glance
Phase 1 · Completed
Enrollment 74 (actual)
Sponsored by Central Institute of Mental Health, Mannheim
Primary completion 2017-08
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Completed
Enrollment
74 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2013-01
Primary completion
2017-08
Eligibility
ALL · 18 Years · 45 Years
Interventions & indications
Sponsors
Central Institute of Mental Health, MannheimLead Sponsor
University of CologneCollaborator
Sites
2 total
Mannheim, GermanyCologne, Germany
Facts & assertions
4 sourced
Enrollment
74
Phase
PHASE1
Primary Completion Date
2017-08
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
company
indication
indication
indication